-
公开(公告)号：EP4238960A8
公开(公告)日：2023-11-22
申请号：EP21886259.7
申请日：2021-10-27
发明人： OKANO, Azusa , TATENO, Yusuke , NODU, Kouhei , SUZUKI, Shinji , AKIYAMA, Toshiyuki , MATOYAMA, Masaaki , AKAZA, Hiroto , FUKUDA, Takashi
IPC分类号： C07D20060101
摘要： The present invention provides a compound represented by formula (I) :
wherein the dashed line indicates the presence or absence of a bond; R 1 is carboxy or the like; L is substituted or unsubstituted non-aromatic carbocyclyldiyl or the like; R 2 is substituted or unsubstituted alkyl; R 3 is a hydrogen atom or the like; X is =CR X -or =N-; Y is =CR Y - or =N-; U is -CR U = or -N=; V is -CR V = or -N=; W is =CR W - or =N-; Z A is -C= or -N-; Z B is -CR 5 R 6 - or the like; Z C is -CR 7 R 8 - or the like; R X , R Y , R V and R W are each independently a hydrogen atom or the like; R U is a hydrogen atom or the like; R 5 and R 6 are each independently a hydrogen atom or the like; R 7 and R 8 are each independently a hydrogen atom or the like; R 4 is substituted or unsubstituted alkyloxy or the like,
or a pharmaceutically acceptable salt thereof, having an antiviral activity; and a pharmaceutical composition comprising the same.-
公开(公告)号：EP4238960A1
公开(公告)日：2023-09-06
申请号：EP21886259.7
申请日：2021-10-27
发明人： OKANO, Azusa , TATENO, Yusuke , NODU, Kouhei , SUZUKI, Shinji , AKIYAMA, Toshiyuki , MATOYAMA, Masaaki , AKAZA, Hiroto , FUKUDA, Takashi
IPC分类号： C07D20060101
摘要： The present invention provides a compound represented by formula (I) :
wherein the dashed line indicates the presence or absence of a bond; R 1 is carboxy or the like; L is substituted or unsubstituted non-aromatic carbocyclyldiyl or the like; R 2 is substituted or unsubstituted alkyl; R 3 is a hydrogen atom or the like; X is =CR X -or =N-; Y is =CR Y - or =N-; U is -CR U = or -N=; V is -CR V = or -N=; W is =CR W - or =N-; Z A is -C= or -N-; Z B is -CR 5 R 6 - or the like; Z C is -CR 7 R 8 - or the like; R X , R Y , R V and R W are each independently a hydrogen atom or the like; R U is a hydrogen atom or the like; R 5 and R 6 are each independently a hydrogen atom or the like; R 7 and R 8 are each independently a hydrogen atom or the like; R 4 is substituted or unsubstituted alkyloxy or the like,
or a pharmaceutically acceptable salt thereof, having an antiviral activity; and a pharmaceutical composition comprising the same.
-
搜索结果
2 条记录 (耗时 0.01 秒)
